English | Español
Patient Daily | Jul 28, 2026

Therapy dog program at Ohio State Wexner Medical Center supports staff wellness
Patient Daily | Jul 28, 2026

TGen joins Collaborative Research Network for Parkinson's disease research
Patient Daily | Jul 28, 2026

Study suggests blocking Axl receptor may promote bone formation in osteoporosis treatment
Patient Daily | Jul 28, 2026

Oak Hill Bio announces SPAC merger to go public on Nasdaq with Roche asset
Patient Daily | Jul 28, 2026

Study finds daily routines reduce pain and depression in older adults
Patient Daily | Jul 28, 2026

THC and CBD combination rapidly reduces agitation in advanced dementia, trial finds
Patient Daily | Jul 28, 2026

Apnimed launches IPO to fund potential sleep apnea drug approval and rollout
Patient Daily | Jul 28, 2026

Experts caution against extreme health-maxxing trends promoted on social media platforms

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'